Venous thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma. The PROTECTOR randomized clinical trial. JAMA Surg 2018; 153: 939-946.
Published: 27th February 2019
Authors: Jung YJ, Seo HS, Park CY, Jeon HM, Kim J-I, Yim HW et al.
This trial that included 682 patients randomized to low molecular weight heparin (LMWH) in addition to intermittent pneumatic compression postoperatively. The addition of LMWH reduced the rate of venous thromboembolism from 3.6 to 0.6 per cent, P=0.008, but increased the risk of bleeding (9.1 versus 1.2 per cent, P<0.001).Pubmed Link
You may also be interested in
Thromboembolism incidence and prophylaxis use after gastrectomy among Korean patients with gastric adenocarcinoma. The PROTECTOR randomized clinical trial. JAMA Surg 2018; 153: 939-946.
Authors: Jung YJ, Seo HS, Park CH, Jeon HM, Kim J-I, Yim HW et al.
Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial. Lancet Haematol 2018; 1: e25-e33.
Authors: Ten Cate-Hoek AJ, Amin EE, Bouman AC, Meijer K, Tick LW, Middeldorp S et al.
Randomized double-blinded study comparing medical treatment versus iliac vein stenting in chronic venous disease. J Vasc Surg Venous Lymphatic 2018; 6: 183-191.
Authors: Rossi FH, Kambara AM, Izukawa NM, Rodrugues TO, Rossi CB, Sousa AG et al.
Edoxaban for the treatment of cancer-associated venous thromboembolism. N Engl J Med 2018; 378: 615-624.
Authors: Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D et al.
Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med 2017; 377: 2240-2252.
Authors: Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ et al.
Rivaroxaban or aspirin for extended treatment of venous thromboembolism. N Engl J Med 2017; 376: 1211-1222.
Authors: Weitz JI, Lensing AWA, Prins MH, Bauersachs R, Bayer-Westendorf J, Bounameaux H et al.
Timing of chemical thromboprophylaxis and deep vein thrombosis in major colorectal surgery: a randomized clinical trial. Ann Surg 2016; 264: 632-639.
Authors: Zaghiyan KN, Sax HC, Miraflor E, Crossman D, Wagner W, Mirocha J et al.
Systematic review and meta-analysis of utility of graduated compression stockings in prevention of post-thrombotic syndrome. Eur J Vasc Endovasc Surg 2016; 51: 838-845.
Authors: Skervin AL, Thapar A, Franchini AJ, Prandoni P, Shaloub J, Davies AH et al.
One versus two years of elastic compression stockings for prevention of post-thrombotic syndrome (OCTAVIA study): randomised controlled trial. BMJ 2016; 353: i2691.
Authors: Mol GC, van de Ree MA, Klok FA, Tegelberg MJ, Sanders FB, Koppen S et al.
Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer. A randomized clinical trial. JAMA 2015; 314: 677-686.
Authors: Lee AYY, Kamphuisen PW, Meyer G, Bauersachs R, Janas MS, Jarner MF et al for the CATCH Investigators et al.
Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism. A randomized clinical trial. JAMA 2015; 313:
Authors: Mismetti P, Laporte S, Pellerin O, Ennezat P-V, Couturaud F, Elias A et al for the PREPIC2 Study Group et al.
Efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials. Eur J Vasc Endovasc Surg. 2014; 48: 565-575.
Authors: Kakkos SK, Kirkilesis GI, Tsolakis IA